176 related articles for article (PubMed ID: 27092942)
1. Construction of minicircle DNA vectors capable of correcting familial hypercholesterolemia phenotype in a LDLR-deficient mouse model.
Hou X; Jiao R; Guo X; Wang T; Chen P; Wang D; Chen Y; He CY; Chen ZY
Gene Ther; 2016 Aug; 23(8-9):657-63. PubMed ID: 27092942
[TBL] [Abstract][Full Text] [Related]
2. Long-term reversal of hypercholesterolemia in low density lipoprotein receptor (LDLR)-deficient mice by adenovirus-mediated LDLR gene transfer combined with CD154 blockade.
Stein CS; Martins I; Davidson BL
J Gene Med; 2000; 2(1):41-51. PubMed ID: 10765504
[TBL] [Abstract][Full Text] [Related]
3. Adeno-associated virus serotype 8 gene therapy leads to significant lowering of plasma cholesterol levels in humanized mouse models of homozygous and heterozygous familial hypercholesterolemia.
Kassim SH; Li H; Bell P; Somanathan S; Lagor W; Jacobs F; Billheimer J; Wilson JM; Rader DJ
Hum Gene Ther; 2013 Jan; 24(1):19-26. PubMed ID: 22985273
[TBL] [Abstract][Full Text] [Related]
4. Long-term physiologically regulated expression of the low-density lipoprotein receptor in vivo using genomic DNA mini-gene constructs.
Hibbitt OC; McNeil E; Lufino MM; Seymour L; Channon K; Wade-Martins R
Mol Ther; 2010 Feb; 18(2):317-26. PubMed ID: 19861949
[TBL] [Abstract][Full Text] [Related]
5. Low-density lipoprotein receptor-deficient hepatocytes differentiated from induced pluripotent stem cells allow familial hypercholesterolemia modeling, CRISPR/Cas-mediated genetic correction, and productive hepatitis C virus infection.
Caron J; Pène V; Tolosa L; Villaret M; Luce E; Fourrier A; Heslan JM; Saheb S; Bruckert E; Gómez-Lechón MJ; Nguyen TH; Rosenberg AR; Weber A; Dubart-Kupperschmitt A
Stem Cell Res Ther; 2019 Jul; 10(1):221. PubMed ID: 31358055
[TBL] [Abstract][Full Text] [Related]
6. Non-physiological overexpression of the low density lipoprotein receptor (LDLr) gene in the liver induces pathological intracellular lipid and cholesterol storage.
Cichon G; Willnow T; Herwig S; Uckert W; Löser P; Schmidt HH; Benhidjeb T; Schlag PM; Schnieders F; Niedzielska D; Heeren J
J Gene Med; 2004 Feb; 6(2):166-75. PubMed ID: 14978770
[TBL] [Abstract][Full Text] [Related]
7. Exosome-based
Li Z; Zhao P; Zhang Y; Wang J; Wang C; Liu Y; Yang G; Yuan L
Theranostics; 2021; 11(6):2953-2965. PubMed ID: 33456582
[TBL] [Abstract][Full Text] [Related]
8. Sleeping Beauty Transposon Vectors in Liver-directed Gene Delivery of LDLR and VLDLR for Gene Therapy of Familial Hypercholesterolemia.
Turunen TA; Kurkipuro J; Heikura T; Vuorio T; Hytönen E; Izsvák Z; Ylä-Herttuala S
Mol Ther; 2016 Mar; 24(3):620-35. PubMed ID: 26670130
[TBL] [Abstract][Full Text] [Related]
9. Infectious delivery of a 135-kb LDLR genomic locus leads to regulated complementation of low-density lipoprotein receptor deficiency in human cells.
Wade-Martins R; Saeki Y; Chiocca EA
Mol Ther; 2003 May; 7(5 Pt 1):604-12. PubMed ID: 12718903
[TBL] [Abstract][Full Text] [Related]
10. A novel peroxisome proliferator response element modulates hepatic low-density lipoprotein receptor gene transcription in response to PPARδ activation.
Shende VR; Singh AB; Liu J
Biochem J; 2015 Dec; 472(3):275-86. PubMed ID: 26443862
[TBL] [Abstract][Full Text] [Related]
11. Impaired adult hippocampal neurogenesis in a mouse model of familial hypercholesterolemia: A role for the LDL receptor and cholesterol metabolism in adult neural precursor cells.
Engel DF; Grzyb AN; de Oliveira J; Pötzsch A; Walker TL; Brocardo PS; Kempermann G; de Bem AF
Mol Metab; 2019 Dec; 30():1-15. PubMed ID: 31767163
[TBL] [Abstract][Full Text] [Related]
12. Helper-dependent adenovirus-mediated gene transfer of a secreted LDL receptor/transferrin chimeric protein reduces aortic atherosclerosis in LDL receptor-deficient mice.
Leggiero E; Labruna G; Iaffaldano L; Lombardo B; Greco A; Fiorenza D; Gramanzini M; Montanaro D; Baldi A; Cerullo V; Sacchetti L; Pastore L
Gene Ther; 2019 Apr; 26(3-4):121-130. PubMed ID: 30700805
[TBL] [Abstract][Full Text] [Related]
13. Gene therapy for rhesus monkeys heterozygous for LDL receptor deficiency by balloon catheter hepatic delivery of helper-dependent adenoviral vector.
Oka K; Mullins CE; Kushwaha RS; Leen AM; Chan L
Gene Ther; 2015 Jan; 22(1):87-95. PubMed ID: 25231173
[TBL] [Abstract][Full Text] [Related]
14. Improving lipoprotein profiles by liver-directed gene transfer of low density lipoprotein receptor gene in hypercholesterolaemia mice.
Ou H; Zhang Q; Zeng J
J Genet; 2016 Jun; 95(2):311-6. PubMed ID: 27350674
[TBL] [Abstract][Full Text] [Related]
15. Adenoviral low density lipoprotein receptor attenuates progression of atherosclerosis and decreases tissue cholesterol levels in a murine model of familial hypercholesterolemia.
Jacobs F; Van Craeyveld E; Feng Y; Snoeys J; De Geest B
Atherosclerosis; 2008 Dec; 201(2):289-97. PubMed ID: 18378244
[TBL] [Abstract][Full Text] [Related]
16. Hepatic overexpression of idol increases circulating protein convertase subtilisin/kexin type 9 in mice and hamsters via dual mechanisms: sterol regulatory element-binding protein 2 and low-density lipoprotein receptor-dependent pathways.
Sasaki M; Terao Y; Ayaori M; Uto-Kondo H; Iizuka M; Yogo M; Hagisawa K; Takiguchi S; Yakushiji E; Nakaya K; Ogura M; Komatsu T; Ikewaki K
Arterioscler Thromb Vasc Biol; 2014 Jun; 34(6):1171-8. PubMed ID: 24675665
[TBL] [Abstract][Full Text] [Related]
17. microRNA-185 modulates low density lipoprotein receptor expression as a key posttranscriptional regulator.
Jiang H; Zhang J; Du Y; Jia X; Yang F; Si S; Wang L; Hong B
Atherosclerosis; 2015 Dec; 243(2):523-32. PubMed ID: 26523989
[TBL] [Abstract][Full Text] [Related]
18. Low-density lipoprotein receptor gene therapy using helper-dependent adenovirus produces long-term protection against atherosclerosis in a mouse model of familial hypercholesterolemia.
Nomura S; Merched A; Nour E; Dieker C; Oka K; Chan L
Gene Ther; 2004 Oct; 11(20):1540-8. PubMed ID: 15269711
[TBL] [Abstract][Full Text] [Related]
19. Long-term stable correction of low-density lipoprotein receptor-deficient mice with a helper-dependent adenoviral vector expressing the very low-density lipoprotein receptor.
Oka K; Pastore L; Kim IH; Merched A; Nomura S; Lee HJ; Merched-Sauvage M; Arden-Riley C; Lee B; Finegold M; Beaudet A; Chan L
Circulation; 2001 Mar; 103(9):1274-81. PubMed ID: 11238273
[TBL] [Abstract][Full Text] [Related]
20. Adenoviral-mediated expression of Pcsk9 in mice results in a low-density lipoprotein receptor knockout phenotype.
Maxwell KN; Breslow JL
Proc Natl Acad Sci U S A; 2004 May; 101(18):7100-5. PubMed ID: 15118091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]